You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global Gene Therapy for Inherited Genetic Disorders Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application


In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome.
Gene therapy has the potential to cure inherited diseases that cannot be cured using conventional drugs. It is being increasingly adopted in clinical trials because of its high efficacy and safety towards the treatment of inherited genetic disorders.

Market Analysis and Insights: Global Gene Therapy for Inherited Genetic Disorders Market
The research report studies the Gene Therapy for Inherited Genetic Disorders market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Gene Therapy for Inherited Genetic Disorders market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Gene Therapy for Inherited Genetic Disorders Scope and Segment
The global Gene Therapy for Inherited Genetic Disorders market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapy for Inherited Genetic Disorders market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Type, the market is primarily split into
Eye Disorders
Hematological Disorders
Central Nervous System Disorders
Muscular Disorders
Others
by Application, this report covers the following segments
Hospital
Clinic
Research Institute
Others
Global Gene Therapy for Inherited Genetic Disorders market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Gene Therapy for Inherited Genetic Disorders key players in this market include:
BioMarin Pharmaceutical Inc.
bluebird bio Inc.
Novartis AG
Orchard Therapeutics Plc
Spark Therapeutics Inc.
1 Market Overview of Gene Therapy for Inherited Genetic Disorders
1.1 Gene Therapy for Inherited Genetic Disorders Market Overview
1.1.1 Gene Therapy for Inherited Genetic Disorders Product Scope
1.1.2 Market Status and Outlook
1.2 Global Gene Therapy for Inherited Genetic Disorders Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Gene Therapy for Inherited Genetic Disorders Market Size by Region (2015-2026)
1.4 Global Gene Therapy for Inherited Genetic Disorders Historic Market Size by Region (2015-2020)
1.5 Global Gene Therapy for Inherited Genetic Disorders Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2015-2026)
1.6.1 North America Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2015-2026)
1.6.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2015-2026)
1.6.4 Latin America Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2015-2026)

2 Gene Therapy for Inherited Genetic Disorders Market Overview by Type
2.1 Global Gene Therapy for Inherited Genetic Disorders Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Gene Therapy for Inherited Genetic Disorders Historic Market Size by Type (2015-2020)
2.3 Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Type (2021-2026)
2.4 Eye Disorders
2.5 Hematological Disorders
2.6 Central Nervous System Disorders
2.7 Muscular Disorders
2.8 Others

3 Gene Therapy for Inherited Genetic Disorders Market Overview by Application
3.1 Global Gene Therapy for Inherited Genetic Disorders Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Gene Therapy for Inherited Genetic Disorders Historic Market Size by Application (2015-2020)
3.3 Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Application (2021-2026)
3.4 Hospital
3.5 Clinic
3.6 Research Institute
3.7 Others

4 Global Gene Therapy for Inherited Genetic Disorders Competition Analysis by Players
4.1 Global Gene Therapy for Inherited Genetic Disorders Market Size by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy for Inherited Genetic Disorders as of 2019)
4.3 Date of Key Manufacturers Enter into Gene Therapy for Inherited Genetic Disorders Market
4.4 Global Top Players Gene Therapy for Inherited Genetic Disorders Headquarters and Area Served
4.5 Key Players Gene Therapy for Inherited Genetic Disorders Product Solution and Service
4.6 Competitive Status
4.6.1 Gene Therapy for Inherited Genetic Disorders Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data
5.1 BioMarin Pharmaceutical Inc.
5.1.1 BioMarin Pharmaceutical Inc. Profile
5.1.2 BioMarin Pharmaceutical Inc. Main Business
5.1.3 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Products, Services and Solutions
5.1.4 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Revenue (US$ Million) & (2015-2020)
5.1.5 BioMarin Pharmaceutical Inc. Recent Developments
5.2 bluebird bio Inc.
5.2.1 bluebird bio Inc. Profile
5.2.2 bluebird bio Inc. Main Business
5.2.3 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Products, Services and Solutions
5.2.4 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Revenue (US$ Million) & (2015-2020)
5.2.5 bluebird bio Inc. Recent Developments
5.3 Novartis AG
5.5.1 Novartis AG Profile
5.3.2 Novartis AG Main Business
5.3.3 Novartis AG Gene Therapy for Inherited Genetic Disorders Products, Services and Solutions
5.3.4 Novartis AG Gene Therapy for Inherited Genetic Disorders Revenue (US$ Million) & (2015-2020)
5.3.5 Orchard Therapeutics Plc Recent Developments
5.4 Orchard Therapeutics Plc
5.4.1 Orchard Therapeutics Plc Profile
5.4.2 Orchard Therapeutics Plc Main Business
5.4.3 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Products, Services and Solutions
5.4.4 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Revenue (US$ Million) & (2015-2020)
5.4.5 Orchard Therapeutics Plc Recent Developments
5.5 Spark Therapeutics Inc.
5.5.1 Spark Therapeutics Inc. Profile
5.5.2 Spark Therapeutics Inc. Main Business
5.5.3 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Products, Services and Solutions
5.5.4 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Revenue (US$ Million) & (2015-2020)
5.5.5 Spark Therapeutics Inc. Recent Developments
...

6 North America
6.1 North America Gene Therapy for Inherited Genetic Disorders Market Size by Country
6.2 United States
6.3 Canada

7 Europe
7.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe

8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific

9 Latin America
9.1 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America

10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa

11 Gene Therapy for Inherited Genetic Disorders Market Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
  • FORMAT: PDF
  • PUBLISHED DATE: Nov, 2020
  • NO OF PAGES: 125